ANNX
Price
$1.90
Change
+$0.01 (+0.53%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
207.36M
20 days until earnings call
STOK
Price
$9.51
Change
+$0.04 (+0.42%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
517.03M
13 days until earnings call
Ad is loading...

ANNX vs STOK

Header iconANNX vs STOK Comparison
Open Charts ANNX vs STOKBanner chart's image
Annexon
Price$1.90
Change+$0.01 (+0.53%)
Volume$53.8K
Capitalization207.36M
Stoke Therapeutics
Price$9.51
Change+$0.04 (+0.42%)
Volume$72.76K
Capitalization517.03M
ANNX vs STOK Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. STOK commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Buy and STOK is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (ANNX: $1.89 vs. STOK: $9.47)
Brand notoriety: ANNX and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 45% vs. STOK: 61%
Market capitalization -- ANNX: $208.46M vs. STOK: $519.22M
ANNX [@Biotechnology] is valued at $208.46M. STOK’s [@Biotechnology] market capitalization is $519.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while STOK’s TA Score has 5 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 4 bearish.
  • STOK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ANNX and STOK are a good buy in the short-term.

Price Growth

ANNX (@Biotechnology) experienced а +12.50% price change this week, while STOK (@Biotechnology) price change was +9.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 18, 2025.

STOK is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($517M) has a higher market cap than ANNX($207M). STOK YTD gains are higher at: -14.143 vs. ANNX (-63.158). STOK has higher annual earnings (EBITDA): -99.2M vs. ANNX (-151.48M). ANNX has more cash in the bank: 312M vs. STOK (217M). STOK has less debt than ANNX: STOK (2.32M) vs ANNX (29M). STOK has higher revenues than ANNX: STOK (36.6M) vs ANNX (0).
ANNXSTOKANNX / STOK
Capitalization207M517M40%
EBITDA-151.48M-99.2M153%
Gain YTD-63.158-14.143447%
P/E RatioN/AN/A-
Revenue036.6M-
Total Cash312M217M144%
Total Debt29M2.32M1,249%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXSTOK
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with STOK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+0.53%
STOK - ANNX
40%
Loosely correlated
-2.97%
ERAS - ANNX
39%
Loosely correlated
+0.72%
RNA - ANNX
39%
Loosely correlated
+1.18%
TRML - ANNX
39%
Loosely correlated
-0.24%
KYMR - ANNX
39%
Loosely correlated
+1.05%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-2.97%
IDYA - STOK
50%
Loosely correlated
+3.95%
RCKT - STOK
49%
Loosely correlated
-0.97%
QTTB - STOK
49%
Loosely correlated
-9.89%
RNA - STOK
48%
Loosely correlated
+1.18%
DNLI - STOK
47%
Loosely correlated
+3.64%
More